CYP3A4 Induction and Mineral Homeostasis
Status: | Active, not recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - 60 |
Updated: | 4/17/2018 |
Start Date: | June 2014 |
End Date: | December 2019 |
Hormonal Regulation of CYP3A
The purpose of this study is to determine whether changes in the activity of the enzyme
CYP3A4 can change the Vitamin D and bone mineral homeostasis.
CYP3A4 can change the Vitamin D and bone mineral homeostasis.
Healthy volunteers will receive one of six interventions for 14 days (determined by
randomization):a). 200 mL of water once a day; b) rifampin 600 mg once a day; c) 200 mL of
grapefruit juice once a day for 8 days plus rifampin 600 mg once a day for 14 days; d)
clarithromycin 250 mg twice a day; f) clarithromycin 250 mg twice a day plus rifampin 600 mg
once a day.
randomization):a). 200 mL of water once a day; b) rifampin 600 mg once a day; c) 200 mL of
grapefruit juice once a day for 8 days plus rifampin 600 mg once a day for 14 days; d)
clarithromycin 250 mg twice a day; f) clarithromycin 250 mg twice a day plus rifampin 600 mg
once a day.
Inclusion Criteria:
- Subjects with no history of significant medical conditions including cardiac,
pulmonary, gastrointestinal, or renal disease, HIV, diabetes mellitus or Hepatitis B
or C
- Subjects will be males or females 18-60 years of age
- Subjects must read and understand English
- Subjects must be able to provide informed consent
- Subjects must be willing to avoid prescription medications, OTC drugs, dietary
supplements and foods that are known to modulate CYP3A4 expression or activity
- Subjects must be willing to maintain a consistent consumption of calcium and Vitamin D
during the study and maintain a daily logbook of their dietary consumption
- Women not currently pregnant or lactating. In addition, women participants of
childbearing age must be willing to utilize a barrier method of birth control
(sterilization will be acceptable)
- Subjects will have no known allergies to the study drugs to be used
- Subject's corrected QTc interval obtained by electrocardiogram will be ≤ 430 ms in men
or ≤ 450 ms in women
Exclusion Criteria:
- Subjects with any significant chronic medical condition, including cardiac, pulmonary,
gastrointestinal, or renal disease, HIV, diabetes mellitus or Hepatitis B or C
- Subjects less than 18 or greater than 60 years of age
- Subjects unable to read and understand English
- Subjects unable to provide informed consent
- Subjects unable to avoid prescription medications, OTC drugs, dietary supplements and
foods that are known to modulate CYP3A4 expression or activity
- Subjects not willing to maintain a consistent consumption of calcium and Vitamin D
during the study and maintain a daily logbook of their dietary consumption
- Women who are pregnant or lactating and women participants of childbearing age not
willing to utilize a barrier method of birth control (sterilization will be
acceptable)
- Subjects with allergies to rifampin, clarithromycin or grapefruit juice
- Potential participants will be excluded if they are concurrently participating in
another research study
- Subjects with corrected QTc interval > 430 ms in men or > 450 ms in women on
electrocardiogram
We found this trial at
1
site
Seattle, Washington 98104
(206) 543-2100
Principal Investigator: Kenneth Thummel, Ph.D.
Phone: 206-616-3294
Univ of Washington Founded in 1861 by a private gift of 10 acres in what...
Click here to add this to my saved trials